Clinical trial TCTR20220518004
Status: Recruiting (according to the registry)Phase 3Latest change: Source: TCTR (Thailand) (via WHO ICTRP)
What's on this page?
This record’s status may be out of date
The trial was registered in May 18, 2022 and still shows as "recruiting" in the registry. Status information in other countries’ registries is often not updated; the trial may have ended or stopped. For current information, check the record itself.
Information in the record
Original title: Efficacy and Safety of Cannabis Transdermal Patch for Alleviating Psoriasis Symptoms: A Randomized Controlled Trial
- Record number
- TCTR20220518004
- Registry
- TCTR (Thailand) (via WHO ICTRP)
- Status
- Recruiting (according to the registry)
- Type and phase
- Clinical trial, phase 3
- Participants
- Target: 60
- Condition (as registered)
- Patients with mild to moderate plaque type psoriasis who willing to apply CanPatch, Psoriasis, Microbiota
- Countries
- Thailand
- Topic in the guide
- Skin Conditions
Timeline
According to the TCTR (Thailand) (via WHO ICTRP) record. Future dates are the investigator’s estimates and may change.
- Registration: May 18, 2022
History
We check the record once a month via WHO ICTRP; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Skin Conditions: guide page · Thinking of taking part? Which specialist to see